Loading…
Based on limited metadata, the FDA issued a warning letter to PharmacyAffiliates.org on August 16, 2018, regarding operations classified as "Other" product type. Without access to the full letter text or specific subject details, the precise nature of the violations cannot be determined from the available information. The issuing office is also not specified in the metadata provided. To understand the specific regulatory concerns and required corrective actions, review of the complete warning letter would be necessary.